Oral Wegovy becomes the first GLP-1 pill indicated for obesity, distinct from Rybelsus, which remains positioned for type 2 diabetes treatment. Daily administration improves acceptability for ...

FDA-approved oral Wegovy (semaglutide) introduces daily administration for chronic weight management, offering weight-loss ...

UnitedHealthcare’s Doula Support introduces a covered doula benefit in eligible employer plans, scaling in phases to reach ...

Widespread skepticism persists about pharmacy-counter pricing, with distrust concentrated among those reporting price ...

Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...

Those days and weeks after a hospitalization are often a demanding, sometimes confusing time for patients, their loved ones ...

Retrospective, single-center design and limited power render findings hypothesis-generating, supporting prospective ...

Postdischarge adverse drug event risk is amplified by frequent medication changes, formulary substitutions, and insurance ...

Fiscal stress reflects rates lagging medical trend; behavioral health utilization far exceeded assumptions (30% vs 3.5%–4%), ...

This month, the Florida Department of Health dramatically reduced the eligibility for their AIDS Drug Assistance Program ...

A TOPOGRAPH-based hierarchy stratifies biomarker–drug pairs from regulatory/positive trial evidence (tiers 1–3A) to ...

Lynavoy is used to treat cholestatic pruritus, an extreme itch that affects almost 90% of patients with primary biliary ...